PlasmonDetect

Key facts

Disease
COVID-19
Known Financial Commitments (USD)
$590,307.11
Funder
European Commission
Principal Investigator
N/A
Research Location
Denmark
Lead Research Institution
Technical University of Denmark (DK)
Research Priority Alignment
N/A

Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Diagnostics
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable

Abstract

Innovation: To overcome the drawbacks of the current standard for testing, PlasmonDetect proposes a novel molecular diagnostic technology called "plasmonic strand-displacement amplification assay" for rapid detection of COVID-19. This technology unites several disciplines and harnesses scientific advances in molecular biology and nanotechnology. Expected Results: The ability to diagnose COVID-19 with a rapid, costeffective method, in a variety of settings, will allow for a significant increase in testing, leading to an improvement in society's response to the pandemic

Publicationslinked via Europe PMC

Last Updated:2 days ago

View all publications at Europe PMC

Development and Validation of the Intimate Partner Violence Workplace Disruptions Assessment (IPV-WDA).

Elucidating directed neural dynamics of scene construction across memory and imagination

Implementing a Novel Resident-Led Peer Support Program for Emergency Medicine Resident Physicians.

Cross-Activity Analysis of CRISPR/Cas9 Editing in Gene Families of <i>Solanum lycopersicum</i> Detected by Long-Read Sequencing.

Creating health systems citizens: enhanced professional identity formation through a para-curricular distinction track in health systems transformation and leadership.

A Comparison of Clinical Diagnostic Classification Criteria Used in Longitudinal Cohort Studies of the Alzheimer's Disease Continuum: A Systematic Review.